Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

• Ansar A. Pathan,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Clare R. Sander,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Helen A. Fletcher,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Ian Poulton,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Nicola C. Alder,

  Affiliation Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford, United Kingdom

  ⨯
• Natalie E. R. Beveridge,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Kathryn T. Whelan,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Adrian V. S. Hill,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Helen McShane

  *To whom correspondence should be addressed. E-mail: helen.mcshane@ndm.ox.ac.uk

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯